Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,347 | -31,929 | -37,874 | -28,575 | -17,691 |
| Depreciation Amortization | 764 | 1,916 | 1,164 | 992 | 96 |
| Accounts payable and accrued liabilities | -110 | -74 | -183 | -378 | 362 |
| Other Working Capital | 461 | -733 | 516 | -11 | 1,209 |
| Other Operating Activity | 2,568 | 6,162 | 2,709 | 4,604 | -204 |
| Operating Cash Flow | $-13,665 | $-24,657 | $-33,669 | $-23,369 | $-16,228 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 5,226 | 3,075 | 9,046 | -17,039 |
| PPE Investments | -3 | -187 | -244 | -800 | -635 |
| Other Investing Activity | -6,527 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-6,530 | $5,039 | $2,831 | $8,245 | $-17,674 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 5,000 | 15,000 | 10,000 | 2,620 |
| Common Stock Issued | 35,068 | 20,863 | 65 | 40,866 | 40 |
| Other Financing Activity | 1,349 | -12,682 | -11,905 | -4,547 | 38,060 |
| Financing Cash Flow | $36,417 | $13,181 | $3,161 | $46,319 | $40,720 |
| Beginning Cash Position | 14,618 | 21,055 | 48,732 | 17,537 | 10,719 |
| End Cash Position | 30,841 | 14,618 | 21,055 | 48,732 | 17,537 |
| Net Cash Flow | $16,223 | $-6,438 | $-27,677 | $31,196 | $6,818 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,665 | -24,657 | -33,669 | -23,369 | -16,228 |
| Capital Expenditure | -3 | -187 | -244 | -800 | -635 |
| Free Cash Flow | -13,667 | -24,844 | -33,913 | -24,169 | -16,863 |